Proton pump inhibitors (PPIs) like omeprazole are among the most commonly prescribed medications and are highly effective for conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and prevention of gastrointestinal bleeding. While they are generally well tolerated, long-term use can contribute to clinically important nutrient deficiencies. I’ve recently come across some scenarios where PPIs may be contributing to B12 and magnesium (excellent board exam nugget to remember), and wanted to share some examples.
Clinical Scenario #1
An 81-year-old long-term care resident has been taking omeprazole for more than five years. Over the last month, nursing staff have noticed increasing muscle cramps and generalized weakness. Laboratory testing reveals low magnesium with a level of 1.1 mg/dL.
PPIs can reduce intestinal magnesium absorption, particularly with prolonged use. Severe hypomagnesemia may lead to muscle cramps, tremors, and even seizures or cardiac arrhythmias in severe cases. Patients taking diuretics or digoxin may be at even greater risk. When low magnesium levels happen, always review the medication list and consider whether chronic PPI therapy may be contributing.
Clinical Scenario #2
A 76-year-old woman has been taking pantoprazole daily for several years. She reports increasing fatigue, numbness in her feet, and mild difficulty with balance. Laboratory testing demonstrates a low vitamin B12 level and associated anemia. Vitamin B12 replacement is initiated, and the necessity of continued PPI therapy is reevaluated.
Vitamin B12 from dietary sources requires gastric acid to separate it from food proteins before absorption. Chronic acid suppression may reduce this process, increasing the risk of vitamin B12 deficiency over time. Symptoms can include fatigue, anemia, memory changes, and peripheral neuropathy. Older adults, those taking metformin, and patients receiving long-term PPI therapy deserve particular attention when these symptoms develop.
I hope you found these scenarios helpful!
0 Comments